keyword
MENU ▼
Read by QxMD icon Read
search

SLE retinopathy

keyword
https://read.qxmd.com/read/30791856/uveal-effusion-and-transient-myopia-as-the-initial-presentation-of-systemic-lupus-erythematosus-patient-with-pulmonary-arterial-hypertension-case-report
#1
Y Wang, Y Yan, J Zhang, J Li
We reported uveal effusion and transient myopia as the initial presentation of systemic lupus erythematosus with pulmonary arterial hypertension. Choroidal retinopathy is rare but extremely destructive to visual function. Therefore, prompt diagnosis and effective treatments will result in complete resolution of the uveal effusion and functional restoration of vision.
February 21, 2019: Lupus
https://read.qxmd.com/read/30755141/evolution-of-retinal-changes-measured-by-optical-coherence-tomography-in-the-assessment-of-hydroxychloroquine-ocular-safety-in-patients-with-systemic-lupus-erythematosus
#2
D Martín-Iglesias, J Artaraz, A Fonollosa, A Ugarte, A Arteagabeitia, G Ruiz-Irastorza
OBJECTIVE: The objective of this report is to analyse retinal changes over a five-year period, assessed by spectral domain-optical coherence tomography (SD-OCT), in patients from the Lupus-Cruces cohort treated with hydroxychloroquine (HCQ). METHODS: SD-OCT screening was performed annually between 2012 and 2017. Average macular thickness (AMT), ganglion cell layer thickness (GCLT) and qualitative data of retinal pigment epithelium (RPE) and external retina (ExtR) were collected prospectively...
February 12, 2019: Lupus
https://read.qxmd.com/read/30639641/take-a-look-at-the-eyes-in-systemic-lupus-erythematosus-a-novel-point-of-view
#3
REVIEW
Paola Conigliaro, Massimo Cesareo, Maria Sole Chimenti, Paola Triggianese, Claudia Canofari, Carmen Barbato, Clarissa Giannini, Ada Giorgia Salandri, Carlo Nucci, Roberto Perricone
Systemic Lupus Erythematosus (SLE) is a connective tissue disease that involves multiple organs. Ocular structures and visual pathways can be affected in SLE because of disease-related eye involvement or drug toxicity. All the part of the eye may be interested with an external, anterior involvement, responsible of the dry eye disease, or posterior (retina) and neuro-ophtalmic manifestations. Retinopathy in SLE is suggestive of high disease activity being a marker of poor visual outcome and prognosis for survival...
January 11, 2019: Autoimmunity Reviews
https://read.qxmd.com/read/30629117/association-of-ultrawide-field-findings-in-proliferative-retinopathy-with-systemic-lupus-erythematosus
#4
Cindy X Cai, Tin Yan Alvin Liu, Catherine B Meyerle
No abstract text is available yet for this article.
January 1, 2019: JAMA Ophthalmology
https://read.qxmd.com/read/30573654/response-to-octa-a-sensitive-screening-for-asymptomatic-retinopathy-raises-alarm-over-systemic-involvements-in-patients-with-sle-by-mizuno-et-al
#5
Conigliaro Paola, Cesareo Massimo, Chimenti Maria Sole, Triggianese Paola, Canofari Claudia, Aloe Gianluca, Nucci Carlo, Perricone Roberto
No abstract text is available yet for this article.
December 20, 2018: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/30522457/intravitreal-dexamethasone-implant-therapy-for-the-treatment-of-cystoid-macular-oedema-due-to-hydroxychloroquine-retinopathy-a-case-report-and-literature-review
#6
Seong Joon Ahn, Jooyoung Joung, Sang Hyup Lee, Byung Ro Lee
BACKGROUND: Cystoid macular oedema (CMO) is an uncommon complication associated with hydroxychloroquine (HCQ) retinopathy threatening central vision. We report a patient with HCQ retinopathy and CMO, for which an intravitreal dexamethasone implant was used, which led to complete resolution of oedema. CASE PRESENTATION: A 57-year-old woman with systemic lupus erythematosus (SLE) complaining of blurred vision in both eyes was diagnosed with bilateral HCQ retinopathy and CMO based on characteristic photoreceptor defects and cystoid spaces on optical coherence tomography, hypo-autofluorescence on fundus autofluorescence, and corresponding visual field defects...
December 6, 2018: BMC Ophthalmology
https://read.qxmd.com/read/30487146/octa-a-sensitive-screening-for-asymptomatic-retinopathy-raises-alarm-over-systemic-involvements-in-patients-with-sle
#7
Yumiko Mizuno, Masayuki Nishide, Taku Wakabayashi, Kohji Nishida, Atsushi Kumanogoh
No abstract text is available yet for this article.
November 28, 2018: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/30401979/hydroxychloroquine-retinopathy-implications-of-research-advances-for-rheumatology-care
#8
REVIEW
April Jorge, Cindy Ung, Lucy H Young, Ronald B Melles, Hyon K Choi
Despite advances in therapy for rheumatic diseases, hydroxychloroquine remains almost universally recommended for the treatment of systemic lupus erythematosus (SLE), and is often used in the management of other rheumatic diseases such as rheumatoid arthritis (RA). However, the major dose-limiting toxicity of hydroxychloroquine is retinopathy that can lead to loss of vision. New highly sensitive screening methods can identify early stages of retinopathy, and studies that include these modalities have indicated a substantially higher prevalence of hydroxychloroquine retinopathy than was previously recognized, resulting in revisions to ophthalmology guidelines and the recommendation of a low dose of hydroxychloroquine for many patients...
December 2018: Nature Reviews. Rheumatology
https://read.qxmd.com/read/30096011/ocular-involvement-in-systemic-lupus-erythematosus-the-experience-of-two-tertiary-referral-centers
#9
Rosanna Dammacco, Pasquale Procaccio, Vito Racanelli, Angelo Vacca, Franco Dammacco
PURPOSE: To assess the prevalence of the ocular manifestations related to the disease and/or ascribable to the administration of potentially toxic drugs in a cohort of 98 patients with systemic lupus erythematosus (SLE). METHODS: Retrospective, observational study reporting the experience of two tertiary referral centers. RESULTS: Overall, an ocular involvement was detected in 29 patients (29.6%), sometimes preceding of months the diagnosis of SLE, more often revealed at diagnosis or throughout its course...
2018: Ocular Immunology and Inflammation
https://read.qxmd.com/read/29948002/lupus-retinopathy-a-marker-of-active-systemic-lupus-erythematosus
#10
Gaurav Seth, K G Chengappa, Durga Prasanna Misra, Ramesh Babu, Pooja Belani, K C Shanoj, Gunjan Kumar, Vir Singh Negi
Retinopathy in the context of systemic lupus erythematosus (SLE) is associated with severe disease and poorer prognosis. We studied retinopathy in our cohort of Indian lupus patients. Four hundred and thirty-seven patients fulfilling the Systemic Lupus International Collaborating Clinics-American College of Rheumatology-2012 criteria, attending the department of Clinical Immunology were enrolled under this cross-sectional study. A comprehensive clinical (including ophthalmological) examination and immunological profile were performed...
August 2018: Rheumatology International
https://read.qxmd.com/read/29243035/systemic-lupus-erythematosus-and-ocular-involvement-an-overview
#11
REVIEW
Rosanna Dammacco
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease of undefined etiology and with remarkably heterogeneous clinical features. Virtually any organ system can be affected, including the eye. SLE-related eye involvement can be diagnosed in approximately one-third of the patients and is usually indicative of disease activity. An early diagnosis and the adoption of suitable therapeutic measures are necessary to prevent sight-threatening consequences, especially in patients with juvenile SLE. Periocular lesions, such as eyelid involvement and orbital inflammation, are relatively rare and, in case of orbital masses, may require a biopsy control...
May 2018: Clinical and Experimental Medicine
https://read.qxmd.com/read/29034159/autoimmune-retinopathy-associated-with-systemic-lupus-erythematosus-a-diagnostic-dilemma
#12
Wadakarn Wuthisiri, Yu-Hung Lai, Jenina Capasso, Martin Blidner, David Salz, Erik Kruger, Alex V Levin
Visual loss in systemic lupus erythematosus (SLE) due to autoimmune retinopathy (AIR) is rare and easily misdiagnosed as hydroxychloroquine retinopathy. We report the rare clinical presentation of severe visual loss in a patient with SLE due to nonparaneoplastic AIR as differentiated from hydroxychloroquine toxicity. A 70-year-old female diagnosed and treated for lupus for 17 years and had been taking hydroxychloroquine for 15 years. Over the past 2 years, she developed progressive peripheral visual loss oculus uterque which rapidly advanced in the latter 6 months...
July 2017: Taiwan Journal of Ophthalmology
https://read.qxmd.com/read/28701214/the-effect-of-oral-acetazolamide-on-cystoid-macular-edema-in-hydroxychloroquine-retinopathy-a-case-report
#13
Eun Hee Hong, Seong Joon Ahn, Han Woong Lim, Byung Ro Lee
BACKGROUND: Hydroxychloroquine (HCQ) retinopathy can accompany other retinal complications such as cystoid macular edema (CME), which leads to central visual loss. We report a case of CME with HCQ retinopathy that improved with the use of oral acetazolamide, and discussed the possible mechanisms of CME in HCQ retinopathy using multimodal imaging modalities. CASE PRESENTATION: A 62-year-old patient with systemic lupus erythematosus (SLE) and HCQ retinopathy developed bilateral CME with visual decline...
July 12, 2017: BMC Ophthalmology
https://read.qxmd.com/read/28695380/macular-capillary-recovery-in-systemic-lupus-erythematosus-complicated-by-kikuchi-fujimoto-disease
#14
Reiko Kinouchi, Motoshi Kinouchi, Akihiro Ishibazawa, Akitoshi Yoshida
PURPOSE: Few case reports have described vaso-occlusive retinopathy in systemic lupus erythematosus (SLE) using optical coherence tomography (OCT) angiography. Here we report the clinical features of a patient with SLE, complicated by Kikuchi-Fujimoto disease, who developed vaso-occlusive retinopathy. We then describe the subsequent recovery of the macular capillaries as assessed by OCT angiography. CASE: A 16-year-old male was referred to us with fever, a 1-month history of violaceous red papules and erythematous plaques on his face and a painful nodule in his right neck...
July 10, 2017: International Ophthalmology
https://read.qxmd.com/read/28394224/neuro-ophthalmologic-manifestations-in-systemic-lupus-erythematosus
#15
REVIEW
F A de Andrade, G Guimarães Moreira Balbi, L G Bortoloti de Azevedo, G Provenzano Sá, H Vieira de Moraes Junior, E Mendes Klumb, R Abramino Levy
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect different ocular structures, such as cornea, conjunctiva, episclera, sclera, uveal tract, retina, optic nerve and vessels. Neuro-ophthalmologic manifestations in SLE include different degrees of involvement of retina, choroid and optic nerve. Retinal changes are one of the most common ocular involvements and are frequently used as clinical criteria for activity, even if isolated. Studies show that up to 29% of patients with active SLE manifest retinal disease...
April 2017: Lupus
https://read.qxmd.com/read/28186509/hydroxychloroquine-retinopathy-an-emerging-problem
#16
M Latasiewicz, H Gourier, I H Yusuf, R Luqmani, S M Sharma, S M Downes
PurposeThe aim of this case series is to raise awareness of the emerging issue of serious retinal damage caused by the prolonged use of hydroxychloroquine (HCQ) and the importance of adequate and appropriate monitoring of visual function during treatment.Patient and methodsThis is a small retrospective case series of 3 patients on long-term HCQ who developed serious symptomatic retinal toxicity confirmed on imaging and functional testing.ResultsAll 3 patients were treated with HCQ for over 15 years; two for rheumatoid arthritis (RA), and the third for systemic lupus erythematosus (SLE)...
June 2017: Eye
https://read.qxmd.com/read/27927040/hydroxychloroquine-in-systemic-lupus-erythematosus-sle
#17
REVIEW
C Ponticelli, G Moroni
Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by increasing the pH. HCQ has proved to be effective in a number of autoimmune diseases including systemic lupus erythematosus (SLE). Areas covered: In this review the mechanisms of action, the efficacy, and the safety of HCQ in the management of patients with SLE have been reviewed. HCQ may reduce the risk of flares, allow the reduction of the dosage of steroids, reduce organ damage, and prevent the thrombotic effects of anti-phospholipid antibodies...
March 2017: Expert Opinion on Drug Safety
https://read.qxmd.com/read/27437561/fluorescein-angiographic-findings-in-patients-with-active-systemic-lupus-erythematosus
#18
Doaa A Tolba, Dina M S El-Fayoumi, Magda S Abdelaziz, Mustafa H Nabih
PURPOSE: To evaluate the retina of patients with active systemic lupus erythematosus (SLE) using fundus fluorescein angiography (FFA), irrespective of their visual acuity or fundus examination. METHODS: A descriptive study was performed on 30 patients with active SLE; disease activity was calculated using The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Fundus examination and FFA angiography were done to all patients. RESULTS: A total of 60 eyes of 30 patients were included...
December 2017: Ocular Immunology and Inflammation
https://read.qxmd.com/read/27174124/role-of-lupus-retinopathy-in-systemic-lupus-erythematosus
#19
Ranju Kharel Sitaula, Dev Narayan Shah, Divya Singh
BACKGROUND: Lupus retinopathy is one of the most common vision-threatening complications of systemic lupus erythematosus. The presence of lupus retinopathy is an accurate guide to the presence of active systemic disease activity. RESULTS: A prospective study was conducted looking at 91 established cases of systemic lupus erythematosus to evaluate lupus retinopathy. The patients were divided into two groups according to the presence or absence of lupus retinopathy, and a comparison of clinical and laboratory findings between two groups was done...
December 2016: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/26922694/purtscher-like-retinopathy-as-a-first-presentation-of-systematic-lupus-erythematosus
#20
Reem M Alahmadi, Rotana T Hashim, Sultan M Almogairin, Ahmed M Abu
Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease, characterized by the involvement of multiple organ systems. Ocular involvement, being one of the manifestations, contributes to the assessment of disease activity. Purtscher-like retinopathy has been reported as a manifestation of SLE. An otherwise healthy 21-year old female presented with a bilateral rapid decrease in vision for 1 month. Fundus examination revealed multiple cotton wool spots and flame-shaped hemorrhages in both eyes...
January 2016: Annals of Saudi Medicine
keyword
keyword
163080
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"